Journal of Bioanalysis & Biomedicine

Joint Event on 13^th International Conference on Biologics and Biosimilars & Biopharma & Biotherapeutics

October 24-25, 2018 | Boston, USA

Keynote

• The end of clinical trials in biosimilars development?

  Francois Xavier Frapaise

  PDF HTML

• Development of biologics and biosimilars in emerging markets - Challenges example Brazil

  Peter H Kalinka

  PDF HTML

• The influence of nanomedicine on drug discovery

  Thomas J Webster

  PDF HTML

• E-BABE: How to address immunogenicity in the development of a rare disease biosimilar

  Candida Fratazzi

  PDF HTML

• Latest developments in biopharmas patient centric drug development paradigm: How to leverage these opportunities and maximize innovation

  Leigh Ann M Durant

  PDF HTML

• FDAs expedited testing and approval: Fast tracking drug approval-what does it take to qualify?

  Aruna Dontabhaktuni

  PDF HTML

• Why so serious?- The increasing impact of post grant challenges to biologics and biosimilars in the US

  Ha Kung Wong

  PDF HTML

• Where the US biosimilars market is going and when it might get there

  Stanton R Mehr

  PDF HTML

• Enabling a global collaborative ecosystem in the realm of biopharma

  Himabindu Gaddipati

  PDF HTML